Trials / Completed
CompletedNCT02031913
Prospective Cohort Study of Association of Insulin Resistance/Steatosis With Hepatic Fibrosis in CHB and NAFLD
Association Between Insulin Resistance and Hepatic Fibrosis in Combined Chronic Hepatitis B and Non-alcoholic Fatty Liver Disease
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (actual)
- Sponsor
- Seoul National University Boramae Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Hepatic steatosis and insulin resistance are associated with severity of fibrosis in non-alcoholic fatty liver disease (NAFLD) and chronic hepatitis C. However, clinical significance of steatosis and insulin resistance on fibrosis in chronic hepatitis B (CHB) is not well established. The aim was to investigate the relationship between insulin resistance, hepatic steatosis, and fibrosis in patients with CHB.
Detailed description
acoustic radiation force impulse elastography
Conditions
Timeline
- Start date
- 2013-01-01
- Primary completion
- 2022-11-01
- Completion
- 2022-12-01
- First posted
- 2014-01-09
- Last updated
- 2023-04-12
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02031913. Inclusion in this directory is not an endorsement.